Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Tumori
|
December 19, 2023
Adjuvant treatment in hormone receptor-positive early breast cancer: New approaches of endocrine therapy
Simone Nardin, Tommaso Ruelle, Irene Giannubilo, et al.
Journal of Clinical Medicine
|
September 28, 2021
How to Protect Ovarian Function before and during Chemotherapy?
Luca Arecco, Tommaso Ruelle, Valentino Martelli, et al.
Breast Cancer (Dove Medical Press)
|
June 3, 2021
Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women
Valentino Martelli, Maria Maddalena Latocca, Tommaso Ruelle, et al.
Journal of Personalized Medicine
|
July 27, 2022
"<i>No Ink on Tumor</i>" in Breast-Conserving Surgery after Neoadjuvant Chemotherapy
Giulia Atzori, Marco Gipponi, Chiara Cornacchia, et al.
European Journal of Clinical Investigation
|
June 15, 2020
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak
Marco Tagliamento, Francesco Spagnolo, Francesca Poggio, et al.
Breast Cancer Research and Treatment
|
November 3, 2021
Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis
Francesca Poggio, Lucia Del Mastro, Marco Bruzzone, et al.
Frontiers in Oncology
|
June 21, 2021
The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast Cancer
Eva Blondeaux, Claudia Massarotti, Valeria Fontana, et al.
Breast (Edinburgh, Scotland)
|
October 2, 2023
Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study
Massimo Di Maio, Claudia Bighin, Francesco Schettini, et al.
Tumori
|
October 15, 2024
Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of Liguria
Irene Giannubilo, Linda Battistuzzi, Tommaso Ruelle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 13, 2024
The journey of patients affected by metastatic hormone receptor-positive/HER2-negative breast cancer from CDK 4/6 inhibitors to second-line treatment: A real-world analysis of 701 patients enrolled in the GIM14/BIOMETA study
Chiara Molinelli, Marco Bruzzone, Eva Blondeaux, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Tumori
|
December 19, 2023
Adjuvant treatment in hormone receptor-positive early breast cancer: New approaches of endocrine therapy
Simone Nardin, Tommaso Ruelle, Irene Giannubilo, et al.
Journal of Clinical Medicine
|
September 28, 2021
How to Protect Ovarian Function before and during Chemotherapy?
Luca Arecco, Tommaso Ruelle, Valentino Martelli, et al.
Breast Cancer (Dove Medical Press)
|
June 3, 2021
Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women
Valentino Martelli, Maria Maddalena Latocca, Tommaso Ruelle, et al.
Journal of Personalized Medicine
|
July 27, 2022
"<i>No Ink on Tumor</i>" in Breast-Conserving Surgery after Neoadjuvant Chemotherapy
Giulia Atzori, Marco Gipponi, Chiara Cornacchia, et al.
European Journal of Clinical Investigation
|
June 15, 2020
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak
Marco Tagliamento, Francesco Spagnolo, Francesca Poggio, et al.
Breast Cancer Research and Treatment
|
November 3, 2021
Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis
Francesca Poggio, Lucia Del Mastro, Marco Bruzzone, et al.
Frontiers in Oncology
|
June 21, 2021
The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast Cancer
Eva Blondeaux, Claudia Massarotti, Valeria Fontana, et al.
Breast (Edinburgh, Scotland)
|
October 2, 2023
Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study
Massimo Di Maio, Claudia Bighin, Francesco Schettini, et al.
Tumori
|
October 15, 2024
Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of Liguria
Irene Giannubilo, Linda Battistuzzi, Tommaso Ruelle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 13, 2024
The journey of patients affected by metastatic hormone receptor-positive/HER2-negative breast cancer from CDK 4/6 inhibitors to second-line treatment: A real-world analysis of 701 patients enrolled in the GIM14/BIOMETA study
Chiara Molinelli, Marco Bruzzone, Eva Blondeaux, et al.
Page
of 2